TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has issued an update.
ASKA Pharmaceutical Holdings Co., Ltd. reported a significant increase in sales for the first quarter of FY2025, driven by strong domestic performance and contributions from overseas operations. Despite the rise in sales, the company’s operating profit decreased due to higher costs associated with R&D and expanded business activities. The financial forecast for FY2025 remains unchanged, with expectations of continued growth in net sales and operating profit.
The most recent analyst rating on (JP:4886) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is engaged in both domestic and overseas markets, with a significant emphasis on research and development to drive product innovation.
Average Trading Volume: 39,087
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen65.55B
For detailed information about 4886 stock, go to TipRanks’ Stock Analysis page.